DOI: 10.1038/ncomms15779

OPEN

Corrigendum: A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action Ning Chai, Lee R. Swem, Summer Park, Gerald Nakamura, Nancy Chiang, Alberto Estevez, Rina Fong, Lynn Kamen, Elviza Kho, Mike Reichelt, Zhonghua Lin, Henry Chiu, Elizabeth Skippington, Zora Modrusan, Jeremy Stinson, Min Xu, Patrick Lupardus, Claudio Ciferri & Man-Wah Tan Nature Communications 8:14234 doi: 10.1038/ncomms14234 (2017); Published 19 Jan 2017; Updated 25 May 2017 This Article contains errors in Fig. 5c. The blue squares should be labelled ‘Water þ 46B8’ and the green triangles should be labelled ‘Tamiflu þ 46B8’. The correct version of Fig. 5 appears below as Fig. 1. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ r The Author(s) 2017

NATURE COMMUNICATIONS | 8:15779 | DOI: 10.1038/ncomms15779 | www.nature.com/naturecommunications

1

CORRIGENDUM a

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15779

Minimum lethal dose

High lethal dose 100 Percent survival

Percent survival

100 80 60 40 20

80 60 Water + control IgG

40

Tamiflu + control IgG Water + 46B8

20 0

0 0

5

10

15

20

25

0

5

10

20

25

Percent BW change

120 100 80

100 80 60 –1 3 4 5 6 7 8 9 10 11 12 13 14 17

60

120

–1 3 4 5 6 7 8 9 10 11 12 13 14 17

Percent BW change

15 Day

Day

Day

Day

b

High lethal dose Treatment initiation

TCID50 ml–1

105 104

Water + control IgG

103

Water + 46B8

10

Tamiflu + control IgG Tamiflu + 46B8

2

101 3

c

4 Day

6

High lethal dose

80 60 40 20 0

0

5

10

15 Day

20

25

120 Water + control IgG 100

Tamiflu + control IgG Water + 46B8

80

Tamiflu + 46B8

60 –1 2 3 4 5 6 8 9 10 11 12 13 14 15 16 17 18 20

Percent BW change

Percent survival

100

Day

Figure 1 |

2

NATURE COMMUNICATIONS | 8:15779 | DOI: 10.1038/ncomms15779 | www.nature.com/naturecommunications

Corrigendum: A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action.

This corrects the article DOI: 10.1038/ncomms14234...
187KB Sizes 0 Downloads 9 Views